Roivant Sciences Ltd (NASDAQ: ROIV) is 2.32% higher on its value in year-to-date trading and has touched a low of $8.24 and a high of $13.24 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ROIV stock was last observed hovering at around $11.19 in the last trading session, with the day’s gains setting it 0.3%.
Currently trading at $11.49, the stock is 5.90% and 5.91% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.82 million and changing 2.68% at the moment leaves the stock 7.93% off its SMA200. ROIV registered 9.74% gain for a year compared to 6-month loss of -0.86%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 4.45% gain in the last 1 month and extending the period to 3 months gives it a 2.32%, and is 2.77% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.71% over the week and 3.12% over the month.
Roivant Sciences Ltd (ROIV) has around 908 employees, a market worth around $8.50B and $158.30M in sales. Current P/E ratio is 2.06. Profit margin for the company is 2991.76%. Distance from 52-week low is 39.36% and -13.22% from its 52-week high. The company has generated returns on investments over the last 12 months (81.76%).
The EPS is expected to shrink by -114.38% this year.
Roivant Sciences Ltd (ROIV) Top Institutional Holders
391.0 institutions hold shares in Roivant Sciences Ltd (ROIV), with institutional investors hold 105.10% of the company’s shares. The shares outstanding are 806.68M, and float is at 443.04M with Short Float at 9.39%. Institutions hold 74.46% of the Float.
The top institutional shareholder in the company is SB INVESTMENT ADVISERS (UK) LTD with over 73.03 million shares valued at $$769.75 million. The investor’s holdings represent 9.1223 of the ROIV Shares outstanding. As of 2024-03-31, the second largest holder is VIKING GLOBAL INVESTORS LP with 69.37 million shares valued at $$731.15 million to account for 8.6648 of the shares outstanding. The other top investors are QVT FINANCIAL LP which holds 66.72 million shares representing 8.3338 and valued at over $$703.23 million, while BLACKROCK INC. holds 4.5201 of the shares totaling 36.19 million with a market value of $$381.42 million.
Roivant Sciences Ltd (ROIV) Insider Activity
The most recent transaction is an insider sale by Venker Eric,the company’sPresident & COO. SEC filings show that Venker Eric sold 96,950 shares of the company’s common stock on Feb 09 ’24 at a price of $10.92 per share for a total of $1.06 million. Following the sale, the insider now owns 0.53 million shares.
Roivant Sciences Ltd disclosed in a document filed with the SEC on Jan 02 ’24 that Ramaswamy Vivek (10% Owner) sold a total of 3,000,000 shares of the company’s common stock. The trade occurred on Jan 02 ’24 and was made at $11.05 per share for $33.15 million. Following the transaction, the insider now directly holds 51.93 million shares of the ROIV stock.
Still, SEC filings show that on Oct 03 ’23, Venker Eric (Chief Operating Officer) disposed off 606,221 shares at an average price of $10.25 for $6.21 million. The insider now directly holds 595,397 shares of Roivant Sciences Ltd (ROIV).
